Detalles de la búsqueda
1.
Comparison of rivaroxaban and low molecular weight heparin in the treatment of cancer-associated venous thromboembolism: a Swedish national population-based register study.
J Thromb Thrombolysis;
2024 May 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38735015
2.
Incidence of hospital-acquired acute kidney injury and trajectories of glomerular filtration rate in older adults.
BMC Nephrol;
24(1): 226, 2023 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37528401
3.
CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical research.
Eur Heart J;
43(37): 3578-3588, 2022 10 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36208161
4.
Pre- and post-stroke oral antithrombotics and mortality in patients with ischaemic stroke.
Pharmacoepidemiol Drug Saf;
31(11): 1182-1189, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35989512
5.
Population-based study of long-term anticoagulation for treatment and secondary prophylaxis of venous thromboembolism in men with prostate cancer in Sweden.
BMC Urol;
22(1): 15, 2022 Feb 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35109829
6.
Time Trends and Treatment Pathways in Prescribing Individual Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation: An Observational Study of More than Three Million Patients from Europe and the United States.
Int J Clin Pract;
2022: 6707985, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35685531
7.
Validation of venous thromboembolism diagnoses in patients receiving rivaroxaban or warfarin in The Health Improvement Network.
Pharmacoepidemiol Drug Saf;
30(2): 229-236, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33009708
8.
Sociodemographic factors and choice of oral anticoagulant in patients with non-valvular atrial fibrillation in Sweden: a population-based cross-sectional study using data from national registers.
BMC Cardiovasc Disord;
19(1): 43, 2019 02 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-30808297
9.
Ascertainment and validation of major bleeding events in a primary care database.
Pharmacoepidemiol Drug Saf;
28(2): 148-155, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29947124
10.
Big data from electronic health records for early and late translational cardiovascular research: challenges and potential.
Eur Heart J;
39(16): 1481-1495, 2018 04 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-29370377
11.
Post authorization safety study comparing quetiapine to risperidone and olanzapine.
Hum Psychopharmacol;
31(4): 304-12, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27297785
12.
Safety profile of rivaroxaban in first-time users treated for venous thromboembolism in four European countries.
PLoS One;
19(3): e0298596, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38451960
13.
Comparison of Clinical Outcomes in Patients with Active Cancer Receiving Rivaroxaban or Low-Molecular-Weight Heparin: The OSCAR-UK Study.
Thromb Haemost;
2024 Apr 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38301711
14.
Challenges and lessons learned from a long-term postauthorisation safety study programme of rivaroxaban in Europe.
BMJ Open;
14(3): e081348, 2024 Mar 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38531587
15.
Big Data in Cardiovascular Disease.
Eur Heart J;
38(24): 1863-1865, 2017 06 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-28863460
16.
Time Trends in Patient Characteristics of New Rivaroxaban Users with Atrial Fibrillation in Germany and the Netherlands.
Drugs Real World Outcomes;
10(2): 215-224, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36725812
17.
Safety and effectiveness of rivaroxaban for prevention of stroke in patients with nonvalvular atrial fibrillation: analysis of routine clinical data from four countries.
Expert Opin Drug Saf;
22(6): 493-500, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36795067
18.
Rivaroxaban versus Apixaban for Treatment of Cancer-Associated Venous Thromboembolism in Patients at Lower Risk of Bleeding.
TH Open;
7(3): e206-e216, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37435565
19.
Effectiveness and Safety of Rivaroxaban and Low Molecular Weight Heparin in Cancer-Associated Venous Thromboembolism.
JACC CardioOncol;
5(2): 189-200, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37144109
20.
Rivaroxaban Versus Low-Molecular-Weight Heparins in a Broad Cohort of Patients With Cancer-Associated Venous Thromboembolism: An Analysis of the OSCAR-US Program.
Clin Appl Thromb Hemost;
29: 10760296231189282, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37583314